n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 69, Issue 1, 2003, Pages 51-59

  Watanabe, S ^a   Doshi, M ^a   Hamazaki, T ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; DOCOSAHEXAENOIC ACID; FISH OIL; OMEGA 3 FATTY ACID; PHOSPHOLIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FATTY ACID SYNTHESIS; FEEDING; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0242492997     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(03)00056-5     Document Type: Article

References (33)

1. N. Yamamoto, M. Saito, A. Moriuchi, M. Nomura, H. Okuyama, Effect of dietary α-linolenate/linoleate balance on brain lipid composition learning ability in rats, J. Lipid Res. 28 (1987) 144-151.
2. T. Moriguchi, R.S. Greiner, N. Salem Jr., Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration, J. Neurochem. 75 (2000) 2563-2573.
3. V.Y. Bolshakov, S.A. Siegelbaum, Hippocampal long-term depression: arachidonic acid as a potential retrograde messenger, Neuropharmacology 34 (1995) 1581-1587.
4. N.G. Bazan, Bioactive lipids in excitatory neurotransmission and neuronal plasticity. Neurochem. Int. 30 (1997) 225-231.
5. P. Needleman, A. Raz, M.S. Minkes, J.A. Ferrendelli, H. Sprecher, Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties, Proc. Natl. Acad. Sci. USA 76 (1979) 944-948.
6. M. Herkenham, A.B. Lynn, M.R. Johnson, L.S. Melvin, B.R. de Costa, K.C. Rice, Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographice study, J. Neurosci. 11 (1991) 563-583.
7. S. Munro, K.L. Thomas, M. Abu-Shaar, Molecular characterization of a peripheral receptor for cannabinoids, Nature 365 (6441) (1993) 61-65.
8. F. Berrendero, S. Nunzio, J.A. Ramos, V. DiMarzo, J.J. Fernandez-Ruiz, Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid levels in the developing rat brain during late gestation and early postnatal period, Synapse 33 (1999) 181-191.
9. 2+-dependent and independent mechanisms, FEBS Lett. 429 (1998) 152-156.
10. T. Sugiura, T. Kodaka, S. Nakane, T. Miyashita, S. Kondo, Y. Suhara, H. Takayama, K. Waku, C. Seki, N. Baba, Y. Shima, Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor, J. Biol. Chem. 274 (1999) 2794-2801.
11. T. Sugiura, S. Kondo, S. Kishimoto, T. Miyashita, S. Nakane, T. Kodama, Y. Suhara, H. Takayama, K. Waku, Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anadmamide is the physiological ligand for the cannabinoid CB2 receptor, J. Biol. Chem. 275 (2000) 605-612.
12. N. Stella, P. Schweitzer, D. Piomelli, A second endogenous cannabinoid that modulates long-term potentiation, Nature 388 (6644) (1997) 773-778.
13. T. Bisogno, D. Melck, L. De Petrocellis, V. Di Marzo, Phosphatidic acid was the biosynthetic precursor of the endocannabionoid 2-arachidonoylglycerol in intact mouse neuroblastoma cells stimulated with ionomycin, J. Neurochem. 72 (1999) 2113-2119.
14. P.C. Schmid, K.D. Schwartz, C.N. Smith, R.J. Krebsbach, E.V. Berdyshev, H.H.O. Schmid, A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamine, 2-monoacylglycerols, Chem. Phys. Lipids 104 (2000) 185-191.
15. H.D. Engler, F.A. Kappal, The production of a bacterial monoglyceride in staphylococcal abscesses, J. Med. Microbiol. 37 (1992) 238-244.
16. E.G. Bligh, W.J. Dyer, A rapid method of total lipid extraction and purification, Can. J. Biochem. Physiol. 37 (1959) 911-917.
17. M.L. Blank, E.A. Cress, V. Fitzgerald, F. Snyder, Thin-layer and high-performance liquid chromatographic separation of glycerolipids subclasses as benzoates, J. Chromatogr. 508 (1990) 382-385.
18. M. Yamada, M. Mizuguchi, S.G. Rhee, S.U. Kim, Developmental changes of three phosphoinositide-specific phospholipase C isozymes in the rat nervous system, Brain Res. Dev. Brain. Res. 59 (1991) 7-16.
19. D.P. Lee, A.S. Deonarine, M. Kienetz, Q. Zhu, M. Skrzypczak, M. Chan, P.C. Choy, A novel pathway for lipid biosynthesis: the direct acylation of glycerol, J. Lipid Res. 42 (2001) 1979-1986.
20. J.P. Terranove, J.J. Storme, N. Lafon, R.-C.M. Perio, G. LeFur, P. Soubrie, Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist SR 14716, Psychopharmacology 126 (1996) 165-172.
21. A.H. Lichtman, SR14716A enhances spatial memeory as assessed in a radial-arm maze task in rats, Eur. J. Pharmacol. 404 (2000) 175-179.
22. M. Reibaud, M.C. Obinu, C. Ledent, M. Parmentier, G.A. Böhme, A. Imperato, Enhancement of memory in cannabinoid CB1 receptor knock-out mice, Eur. J. Pharmacol. 379 (1999) R1-R2.
23. G. Marsicano, C.T. Wotjak, S.C. Azad, T. Bisgno, G. Rammes, M.G. Cascio, H. Hermann, J. Tang, C Hofmann, W. Zieglgäbsberger, V. Di Marzo, B. Lutz, The endogenous cannabinoid system controls extinction of aversive memories, Nature 418 (6897) (2002) 530-534.
24. M. Martin, C. Ledent, M. Parmentier, R. Maldonado, O. Valverde, Involvement of CB1 cannabinoid receptors in emotional behavior, Psychopharmacology 159 (2002) 379-387.
25. S.Y. Lim, H. Suzuki, Intakes of dietary docosahexaenoic acid ethyl ester and egg phosphatidylcholine improve maze-learning ability in young and old mice, J. Nutr. 130 (2000) 1629-1632.
26. A. Berger, G. Crozier, T. Bisogno, P. Cavaliere, S. Innis, V. Di Marzo, Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamides in piglets, Proc. Natl. Acad. Sci. USA 98 (2001) 6402-6406.
27. V. Di Marzo, A. Fontana, H. Cadas, S. Schinelli, G. Cimino, J.C. Schwartz, D. Piomelli, Formation and inactivation of endogenous cannabinoid anandamide in central neurons, Nature 372 (6507) (1994) 686-691.
28. W.A. Devane, J. Axelrod, Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes, Proc. Natl. Acad. Sci. USA 91 (1994) 6698-6701.
29. T. Bisogno, I. Delton-Vandenbroucke, A. Milone, M. Lagarde, V. Di Marzo, Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina, Arch. Biochem. Biophys. 370 (1999) 300-307.
30. F. Berrendero, N. Sepe, J.A. Ramos, V. Di Marzo, J.J. Fernandez-Ruiz, Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid levels in the developing rat brain during late gestation and early postnatal period, Synapse 33 (1999) 181-191.
31. T.C. Kirkham, C.M. Williams, F. Fezza, V. Di Marzo, Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol, Br. J. Pharmacol. 136 (2002) 550-557.
32. D. Panikashvili, C. Simeonidou, S. Ben-Shabat, L. Hanus, A. Breuer, R. Mechoulam, E. Shohami, An endogenous cannabinoid (2-AG) is neuroprotective after brain injury, Nature 413 (6855) (2001) 527-531.
33. V. Di Marzo, M.P. Hill, T. Bisogno, A.R. Crossman, J.M. Brotchie, Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's diseases, FASEB J. 14 (2000) 1432-1438.